Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Delcath Systems, Inc. (DCTH : NSDQ)

• Company Description    Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. Number of Employees: 96

• Price / Volume Information    Yesterday's Closing Price: $10.10 Daily Weekly Monthly 20 Day Moving Average: 437,540 shares Shares Outstanding: 35.31 (millions) Market Capitalization: $356.67 (millions) Beta: 0.39 52 Week High: $18.23 52 Week Low: $8.12 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.80% 0.97% 12 Week -7.17% -8.67% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 566 QUEENSBURY AVENUE - QUEENSBURY,NY 12804 USA ph: 518-743-8892 fax: 212-489-2102 investorrelations@delcath.com http://www.delcath.com

• General Corporate Information    Officers Gerard Michel - Chief Executive Officer and Director John R. Sylvester - Chairman of the Board Sandra Pennell - Chief Financial Officer Elizabeth Czerepak - Director Steven Salamon - Director Peer Information Delcath Systems, Inc. (ABMD) Delcath Systems, Inc. (DMDS) Delcath Systems, Inc. (CPWY.) Delcath Systems, Inc. (EQUR) Delcath Systems, Inc. (ECIA) Delcath Systems, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 24661P807 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/05/26 Share - Related Items Shares Outstanding: 35.31 Most Recent Split Date: 12.00 (0.00:1) Beta: 0.39 Market Capitalization: $356.67 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.13 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.58 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/05/26

• Fundamental Ratios P/E Current FY Estimate: 17.41 Trailing 12 Months: 59.41 PEG Ratio: - Price Ratios Price/Book: 3.11 Price/Cash Flow: - Price / Sales: 4.48 EPS Growth vs. Year Ago Period: 166.67% vs. Previous Quarter: -71.43% Sales Growth vs. Year Ago Period: 83.60% vs. Previous Quarter: -14.87% ROE 12/31/25 - - 09/30/25 - 7.02 06/30/25 - 6.91 ROA 12/31/25 - - 09/30/25 - 6.39 06/30/25 - 5.80 Current Ratio 12/31/25 - - 09/30/25 - 15.06 06/30/25 - 10.88 Quick Ratio 12/31/25 - - 09/30/25 - 13.71 06/30/25 - 9.87 Operating Margin 12/31/25 - - 09/30/25 - 8.13 06/30/25 - 6.45 Net Margin 12/31/25 - - 09/30/25 - 1.50 06/30/25 - 3.18 Pre-Tax Margin 12/31/25 - - 09/30/25 - 1.82 06/30/25 - 4.18 Book Value 12/31/25 - - 09/30/25 - 3.25 06/30/25 - 3.01 Inventory Turnover 12/31/25 - - 09/30/25 - 1.24 06/30/25 - 1.27 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©